Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SZSE:301033's Dividend Yield % is ranked worse than 65.81% of 313
companies
in the Medical Devices & Instruments industry
Industry Median: 2.03
vs SZSE:301033: 1.37
During the past 12 months, Medprin Regenerative Medical Technologies Co's average Dividends Per Share Growth Rate was 16.70% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 81.70% per year.
During the past 8 years, the highest 3-Year average Dividends Per Share Growth Rate of Medprin Regenerative Medical Technologies Co was 81.70% per year. The lowest was 81.70% per year. And the median was 81.70% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Medprin Regenerative Medical Technologies Co (SZSE:301033) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medprin Regenerative Medical Technologies Co Dividend Yield % Chart
Medprin Regenerative Medical Technologies Co Annual Data
SZSE:301033 vs ABT, SYK, MDT: Dividend Yield % Comparison
For the Medical Devices subindustry, Medprin Regenerative Medical Technologies Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medprin Regenerative Medical Technologies Co Dividend Yield % vs Medical Devices & Instruments Industry
Medprin Regenerative Medical Technologies Co Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Medprin Regenerative Medical Technologies Co Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
CNY 0.700000
2026-06-01
2026-05-29
2026-06-01
Cash Dividend
annually
CNY:CNY 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medprin Regenerative Medical Technologies Co (SZSE:301033) has a Dividend Yield % of 1.37% as of Sep. 17, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Medprin Regenerative Medical Technologies Co and its competitors. This is 93% above median its historical median of 0.71. Over the past decade, Medprin Regenerative Medical Technologies Co's Dividend Yield % has ranged from 0.19 to 1.37. According to the industry distribution chart, Medprin Regenerative Medical Technologies Co ranks #206 out of 313 companies in the Medical Devices & Instruments industry, placing it in the top 65.8%.
Is Medprin Regenerative Medical Technologies Co's Dividend Yield % too high?
Medprin Regenerative Medical Technologies Co's current Dividend Yield % of 1.37% is 93% above median its 10-year median of 0.71. Over the past 10 years, this metric has ranged from a low of 0.19 to a high of 1.37. The Medical Devices & Instruments industry median Dividend Yield % is 2.03. Medprin Regenerative Medical Technologies Co's value of 1.37% is 32.5% below this industry median. Based on the distribution chart, Medprin Regenerative Medical Technologies Co ranks #206 out of 313 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Medprin Regenerative Medical Technologies Co has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medprin Regenerative Medical Technologies Co's Dividend Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medprin Regenerative Medical Technologies Co ranks #206 out of 313 companies for Dividend Yield %. This places Medprin Regenerative Medical Technologies Co in the lower half of its industry. The industry median Dividend Yield % is 2.03. Medprin Regenerative Medical Technologies Co's value of 1.37% is 32.5% below this benchmark. Historically, Medprin Regenerative Medical Technologies Co's own Dividend Yield % has ranged from 0.19 to 1.37 over the past decade. While the company's 10-year median is 0.71 vs. the industry median of 2.03, Medprin Regenerative Medical Technologies Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Medical Devices & Instruments company?
The median Dividend Yield % among Medical Devices & Instruments companies is 2.03, based on 313 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medprin Regenerative Medical Technologies Co's current Dividend Yield % of 1.37% is 32.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Medprin Regenerative Medical Technologies Co and its competitors. For the Medical Devices & Instruments industry, the median Dividend Yield % is 2.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medprin Regenerative Medical Technologies Co's current Dividend Yield % is 1.37%, which is 93% above median its own 10-year median of 0.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medprin Regenerative Medical Technologies Co stock overvalued right now?
Based on GuruFocus' analysis, Medprin Regenerative Medical Technologies Co (SZSE:301033) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥73.38, compared to a current price of ¥52.90 — trading 27.9% below its estimated fair value. The current Dividend Yield % is 1.37%, which is 93% above median its 10-year median of 0.71 and 32.5% below the Medical Devices & Instruments industry median of 2.03. Medprin Regenerative Medical Technologies Co's overall GF Score™ is 78/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Medprin Regenerative Medical Technologies Co (SZSE:301033), the current Dividend Yield % is 1.37% as of Sep. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medprin Regenerative Medical Technologies Co (SZSE:301033) Overvalued in 2026?
Based on GuruFocus' analysis, Medprin Regenerative Medical Technologies Co stock appears to be undervalued.
The current stock price of ¥52.90 is trading 27.9% below its estimated GF Value™ of ¥73.38.
GuruFocus considers Medprin Regenerative Medical Technologies Co to be Modestly Undervalued.
Key valuation signals for SZSE:301033:
Dividend Yield %: 1.37% (93% above median its 10-year median of 0.71)
GF Value™: ¥73.38 vs. price of ¥52.90 (27.9% below fair value)
Industry Position: 32.5% below the Medical Devices & Instruments median (#206 of 313)
No single metric tells the full story. See the SZSE:301033 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:301033 has been successfully added to your 
